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Determining the Role of the Aromatic Ring of N-Arylmethyl ent-
conduramine F-1 in their Interactions with a-Glucosidases by Saturation
Transfer Difference NMR Spectroscopy Experiments
Antonio Hernndez Daranas,*[a] Sonia Koteich Khatib,[a, b] Robert Lysek,[c] Pierre Vogel,[c] and Jos A. Gavn*[a]
Glucosidases are a group of enzymes responsible of the glyco-
sidic bond cleavage with different specificities depending on
the number of monosaccharides, the position of cleavage, and
the configuration of the hydroxy groups in their substrates. In
particular, inhibitors of a-1,4-glucosidases have generated
great interest as potential therapeutic agents for the treatment
of type II diabetes (e.g. , miglitol (N-2-hydroxyethyl-1-deoxyno-
jirimycin), Glyset, Diastabol, Glucobay),[1, 2] obesity,[3] hepatitis B
and C[4,5] and other viral diseases,[6] and cancer.[7]
Previously, we have shown that N-benzylation of (+)-ent-
conduramine F-1 (1) significantly increases its inhibitory activity
toward a-1,4-glucosidase from yeast.[8] Because of their rela-
tively high hydrophobicity, N-benzyl derivatives of 1 might rep-
resent a-1,4-glucosidase inhibitors with improved bioavailabil-
ity and pharmacokinetics.[9] So far, rational drug design has not
been applied to inhibitors of a-1,4-glucosidases, because the
structural information available is very scarce and only related
to the free forms of the protein. The lack of structural informa-
tion on the nature of the interactions between a-1,4-glucosi-
dases and their inhibitors has made it a difficult task to discov-
er good lead compounds. In this work, we have attempted to
understand the role of the aryl moieties in improving the in-
hibitory activities of N-benzyl derivatives of 1 using saturation
transfer difference (STD) NMR spectroscopy. The method
allows the binding of a ligand to a receptor to be characterize
by using small amounts of protein (micromolar range), and it
is very useful for mapping the binding epitope of the ligand
with atomic resolution. Ligand protons that are in close con-
tact with the protein binding pocket experience a larger frac-
tion of saturation transfer than protons further away.[10] Thus,
protons of ligand directly involved in binding show larger
signal increments than other ligand protons in STD NMR spec-
tra.
a-1,4-Glucosidase from Saccharomyces cerevisiae was used in
this study as a model system to evaluate the interactions of
ligand 1 and its N-benzyl derivatives 2–4 with the enzyme by
STD NMR spectroscopy (Figure 1). Significant STD effects were
observed for all ligands in the presence of a-1,4-glucosidase,
which indicated that they are bound to the enzyme under the
test conditions. In addition, to validate the stability of the in-
hibitors, 1H NMR spectra of the complexes were acquired after
being left in solution for several days, and hydrolysis products
were not observed.
The size of the observed STD effect does not only depend
on the proximity of the proton to the receptor. In fact, if the
longitudinal relaxation times (T1) of individual ligand protons
are quite different, there is a severe interference on the epi-
tope map for ligand–receptor interactions derived from STD
measurements.[11] Therefore, it is essential to consider the im-
portance of this circumstance on STD experiments performed
for molecules that have protons with substantially different T1
values. Measurements of T1 values for individual ligand pro-
tons in complex with a-1,4-glucosidase were undertaken for all
ligands (Table 1). In general, H4 and H5 showed longer T1
values in all inhibitors, and important relative differences were
observed within each ligand, with the exception of 2 that
showed T1 values of 0.4–0.6 s.
Figure 1. Chemical structures of compounds 1–4. The inhibitory activities
are also shown as IC50 and Ki values.
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The use of saturation times shorter than T1 has been sug-
gested for improving the accuracy of STD results. However,
under these conditions, poor signal-to-noise ratios are usually
obtained due to low magnetization transfer from the recep-
tor.[11] To overcome this problem, we decided to use STD initial
growing rates (STD0), calculated from the fitting of the satura-
tion time data to monoexponential Equation (1):
STD ¼ STDmaxð1eðksat TsatÞÞ ð1Þ
where STD stands for the STD signal intensity of a given
proton at saturation time Tsat, STDmax is the maximal STD inten-
sity obtainable, and ksat stands for the observed saturation rate
constant.[12] Therefore, STD data were acquired on samples
containing each ligand in the presence of a-1,4-glucosidase
(200:1 molar ratio) at a series of saturation times (Tsat=0.25,
0.5, 1, 2, 3, 5 s), as shown in Figure 2a. As a representative ex-
ample, STD build-up curves for ligand 3 can be seen in Fig-
ure 2b.
Clearly, the signal enhancement for the protons with shorter
T1 values (0.29 s for H3’’ and H5’’) have already reached a pla-
teau after 1 s. A slightly longer time was observed for H7 that
showed the second shorter T1 value (0.46 s). Conversely, the
other protons still developed signal up to saturation times
around 2 or 3 s depending on their T1 values (longer than
0.8 s in all cases). Similar results were obtained for the other
ligands.
We believe that when comparing ligands with similar struc-
tures that bind into the same binding site, the important point
is to focus on the overall pattern, and but not on the individu-
al values of each proton. For example, for inhibitors 2–4, the
STD enhancements are larger for the aromatic protons than for
the conduramine protons (Table 2). In addition, it should be
noted that the relative differences observed are bigger for the
ligand with a tryptophan moiety (4), followed by the ligand
with a pyridine ring (3), and finally by the phenolic derivative
(2), for which the differences are not so important. If the pur-
pose of N-benzylation of 1 was to add a substituent that
would simply expel water molecules from the a-1,4-glucosi-
dase active site and thus increase the binding constant[13,14] be-
cause of more a favorable binding entropy,[15] we would
expect the opposite behavior: larger STD effects at the H1 to
H4 positions due to specific interactions (hydrogen bond) be-
tween the conduramine and the enzyme.[16] Thus, the role of
the N-substituents in 2–4 should be to interact directly with
the protein. We also observed that the conduramine protons
are affected by N-benzylation, independent of the nature of
the aromatic ring of the inhibitor following the same general
trend: H1,2,3 always show the smallest STD effect, whereas the
olefinic protons H5,6 show a slight enhancement of the signal
intensity in 2–4 compared with the olefinic signals of 1.
The enzyme used in our NMR spectroscopy experiments was
a-1,4-glucosidase derived from the yeast, S. cerevisiae. Unfortu-
nately, although it is well known that the MAL12 gene regu-
lates the expression of this enzyme, as yet, no experimental 3D
information is available. However, a number of homologous se-
quences with 3D structures deposited at the Protein Data Bank
(PDB) are available and were found by using a basic local align-
ment search tool program (BLASTP) search.[17] Of these sequen-
ces, the oligo-1,6-glucosidases from S. cerevisiae (PDB: 3AJ7)[18]
and Bacillus cereus (PDB: 1UOK)[19] showed the highest se-
quence identity (72% and 38.5%, respectively) compared with
the sequence of a-1,4-glucosidase from S. cerevisiae (see Sup-
porting Information). Therefore, taking into account the good
sequence identity between the a-1,4-glucosidase and the
oligo-1,6-glucosidase from S. cerevisiae, we decided to build a
theoretical model of a-1,4-glucosidase using homology model-
ing techniques.[20] In fact, in a-1,4-glucosidase, the catalytic
triad D215, E277, D352 characteristic of oligo-1,6-glucosidase
is conserved (D211, E273, D346 in a-1,4-glucosidase) together
with the residues D69, H112, R213, H351, and R442 (D65,
H108, R209, H345, and R436 in a-1,4-glucosidase), which have
been found to participate in a hydrogen-bond network within
the active site of oligo-1,6-glucosidase.[18]
Molecular docking simulations were then undertaken to
gain further insight into the most probable binding mode of
the studied ligands.[21] Considering that the residues within the
active site of several members of the glycoside hydrolase
family are highly conserved, we defined the binding site of
Table 1. Longitudinal relaxation times (T1) calculated for ligands 1–4 in
complex with a-1,4-glucosidase.[a]
1 T1 2 T1 3 T1 4 T1
H1 0.93 H1/H2 0.42 H1/H2 0.77 H1/H2 0.88
H2 1.05 H3 0.52 H3 0.81 H3 1.17
H3 1.14 H4 0.57 H4 1.09 H4 1.52
H4 1.41 H5 0.60 H5 1.05 H5 1.25
H5 1.78 H6 0.53 H6 0.81 H6 0.87
H6 1.28 H7 0.29 H7 0.46 H2’ 1.08
H2’/H6’ 0.58 H2’/H6’ 0.86 H5’ 1.99
H3’/H5’ 0.69 H3’/H5’ 0.89 H6’ 1.26
H2’’/H6’’ 0.77 H7’ 1.27
H3’’/H5’’ 0.29 H8’ 1.23
NAc 4.70
[a] T1 values for individual protons measured for each inhibitor in com-
plex with a-1,4-glucosidase are noted in seconds (s).
Table 2. Saturation transfer difference (STD) effects calculated for ligands
1–4 in complex with a-1,4-glucosidase.[a]
1 STDfit 2 STDfit 3 STDfit 4 STDfit
H1 98 H1/H2 79 H1/H2 124 H1/H2 143
H2 41 H3 54 H3 94 H3 71
H3 64 H4 100 H4 100 H4 100
H4 100 H5 97 H5 127 H5 143
H5 71 H6 101 H6 133 H6 200
H6 65 H7 110 H7 97 H2’ 386
H2’/H6’ 121 H2’/H6’ 200 H5’ 1029
H3’/H5’ 147 H3’/H5’ 245 H6’ 1429
H2’’/H6’’ 303 H7’ 643
H3’’/H5’’ 273 H8’ 471
NAc 29
[a] STDfit corresponds to the relative STD intensity for each ligand calcu-
lated from fitting the data to monoexponential Equation (1).
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a-1,4-glucosidase around those residues. To validate our re-
sults, the docked conformations for each ligand were superim-
posed and compared with the crystal structure of oligo-1,6-
glucosidase in complex with maltose (PDB: 3A4A).[18] The simu-
lation results predict that all ligands interact with the active
site residues in a very similar way, which suggests that the
docking protocol was reasonable in identifying the binding
conformation accurately.
The four ligands used in this study share the ent-condura-
mine moiety, although ligands 2–4 also include different aro-
matic moieties. The best docking solutions for all ligands show
almost superimposable poses for their respective ent-condura-
mine moieties, although the aromatic rings are ac-
commodated in slightly different positions. Therefore,
as otherwise stated, our discussion is common to all
ligands. A visual assessment and a ligplot[22] analysis
of the results suggested that an extensive hydrogen-
bond network could be formed between the ent-con-
duramine and several residues within the active site.
In fact, R436 can form a hydrogen bond with the hy-
droxy groups at C2 and C4 (2.75–2.85 ). In addition,
the hydroxy group at C4 is also in a good position to
form a hydrogen bond with D65 (2.7 ). The hydroxy
group at C3 could form hydrogen bonds with the
catalytic residues D211 (2.9 ) and D346 (3.0–3.2 ),
or even with H345, although this residue is located
slightly further away (3.3–3.4 ). Likewise, the amine
group at C1 could be involved in a hydrogen bond
with T212, and the double bond at C5–C6 could po-
tentially interact positively with F174. With regard to
the aromatic moieties of the studied ligands, our sim-
ulations predict that although the binding cavity is
narrow, there is enough space to accommodate
them. In fact, the aromatic rings of ligands 2 and 4
could be stabilized by several hydrophobic contacts
with F155 and A275, and our model suggests they
would essentially be sandwiched by F154 and F297,
with each residue interacting with a different face of
the ligand. For inhibitor 3, in addition to the previ-
ously mentioned contacts, modeling also predicts in-
teractions with H236 and H276 due to its bigger size
(see Figure 3 and the Supporting Information).
In conclusion, introduction of aromatic moieties on
iminosugars and their analogues might decrease[24,25]
or increase[26] their inhibitory activity against different
glycosidases. In the case of (+)-ent-conduramine F-1
(1), which is a moderate inhibitor of a-1,4-glucosidas-
es, N-benzylation gives a derivative with significantly
increased inhibitory activity. By applying STD NMR
spectroscopy, we have demonstrated for the first
time that the aromatic moieties of N-benzyl ent-con-
duramine F-1 derivatives interact strongly with a-1,4-
glucosidase from S. cerevisiae—more strongly than
the conduramine moiety. Interestingly, upon N-ben-
zylation of 1, the olefinic protons experience en-
hanced interaction with the enzyme, but this is not
true for the other protons in the ligand.
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Figure 2. a) STD build-up curves for all protons in ligand 3. Experimental data were fitted
to a rising exponential to calculate Ksat and STD. b) Reference NMR spectrum of a mixture
of compound 3 and 0.15 mm of a-1,4-glucosidase in a 200:1 molar ratio. STD NMR spec-
tra obtained at increasing saturation times of 0.25, 0.5, 1, 2, 3, and 5 s (from bottom to
top).
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Figure 3. Docked conformation obtained for ligand 3 in the modeled a-1,4-glucosidase
active site. Only those residues within a distance of 4  of the ligand are shown. The mo-
lecular surface of the binding cavity is shown in yellow. The ligand is depicted with
green bonds for clarity.
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